Skip to content

Clinical trials

Completed Phase 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelogenous, Chronic, BCR-ABL Positive Phase: Phase 1 Status: Completed Clear all

86 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20014
20023
20034
20041
20056
20069
20072
20086
20093
20109
20114
20127
20134
20146
20153
20162
20171
20182
20191
20201
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed86

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center9
Novartis Pharmaceuticals8
National Cancer Institute (NCI)7
National Heart, Lung, and Blood Institute (NHLBI)4
Jonsson Comprehensive Cancer Center3
Bristol-Myers Squibb2
Case Comprehensive Cancer Center2
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.2
H. Lee Moffitt Cancer Center and Research Institute2
Masonic Cancer Center, University of Minnesota2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelogenous, Chronic, BCR-ABL Positive86
Precursor Cell Lymphoblastic Leukemia-Lymphoma40
Leukemia, Myeloid, Acute34
Leukemia, Lymphocytic, Chronic, B-Cell27
Myelodysplastic Syndromes27
Leukemia25
Lymphoma, Non-Hodgkin17
Multiple Myeloma16
Hodgkin Disease15
Blast Crisis13

Trials

Showing 1 to 25 of 86. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.